Academician of the Chinese Academy of Engineering, chief physician, professor, and doctoral supervisor. He is currently the director of the Neurosurgery Center of Beijing Tiantan Hospital affiliated to Capital Medical University, the director of Beijing Neurosurgery Institute, the vice president of the School of Neurosurgery of Capital Medical University, and the deputy director of the National Center for Neurological Diseases. He is the first chairman of the Glioma Professional Committee of the Chinese Medical Doctor Association and the Chinese Anti-Cancer Association. He is currently the president of the Beijing Medical Science and Health Society, the chairman of the Asian Glioma Genome Atlas Project, and the Chinese chairman of the Global Glioma Clinical Trial Project. Editor-in-chief of "Neurological Diseases and Mental Health", deputy editor-in-chief of "Journal of Clinical Surgery", deputy editor-in-chief of "Chinese Clinical Practical Medicine", and deputy editor-in-chief of "Cancer Biology & Medicine".

He has been engaged in medical, teaching and research work in the field of comprehensive treatment of brain tumors for a long time. He has built the world's largest multidimensional genomics database of brain gliomas, leading the world's individualized diagnosis and treatment of gliomas based on molecular pathology. He took the lead in conducting molecular pathology research on gliomas in China and introduced molecular typing into glioma classification before WHO. He discovered the fusion gene PTPRZ1-MET that promotes the malignant progression and drug resistance of gliomas, and developed the original targeted drug PLB-1001. The results were published in Cell and won the Top Ten Advances in Chinese Life Sciences in 2018. He took the lead in carrying out awakening surgery in China and established a technical system for motor area protection; established a multilingual language area precision positioning protection plan, and created a staged resection procedure for gliomas in the language function area, with significantly better results than international reports. He has published 362 papers and 10 cover papers in high-level journals such as Cell and PNAS as the corresponding author; he has been cited 15,700 times and has an H index of 66. There are 23 papers in the top 1% of highly cited papers, 46 of which are included in domestic and foreign guidelines, and 20 are cited by international policy documents. He presided over the formulation of multiple diagnosis and treatment guidelines and specifications such as the "Diagnosis and Treatment Specifications for Brain Glioma" and "Diagnosis and Treatment Guidelines for Brain Glioma" of the National Health Commission, and edited a unified textbook. He has obtained 1 Class III medical device registration certificate and 25 domestic and foreign patents. As the first finisher, he won 1 second prize of the National Science and Technology Progress Award, 3 first prizes at the provincial and ministerial levels, and the 14th Guanghua Engineering Science and Technology Award. He was awarded the title of Outstanding Communist Party Member of the Beijing Health System and Advanced Worker of Beijing, and was selected as a Beijing Scholar in 2019 and a member of the Academic Advisory Committee of the Chinese Academy of Medical Sciences. The precision diagnosis and treatment team for brain gliomas led by him was named the Beijing Worker Pioneer in 2022.

Michael Brainin is an Austrian neurologist and emeritus professor at the Danube University Krems. He is widely known as a pioneer in stroke research and prevention as well as a leading figure in the development of stroke units. Brainin was president of the Austrian Stroke Society, the European Stroke Organisation and the World Stroke Organization.

In 1998, Brainin co-founded the Austrian Stroke Society (ÖGSF) and was elected as its first president, where he pioneered the planning and establishment of acute stroke units. He also established the first stroke database in Austria, from which the Austrian Stroke Unit Register emerged.

From 2012 to 2014, Brainin was President of the European Stroke Organization (ESO)and from 2018 to 2020, he was President of the World Stroke Organization (WSO). In this global position he propagated the similarities of prevention strategies for stroke as well as dementia and published the "Declaration on the Prevention of Stroke and Dementia" while also developing the project 'Cut Stroke in Half'. From 2008 to 2017, Brainin was also head of the Education Committee of the WSO. In this function, he supported the development of a global network of stroke researchers as well as the educational programs for stroke physicians in numerous countries. Brainin also co-founded the World Stroke Academy, a web-based learning platform. Together with Wolf-Dieter Heiss, he developed the European Stroke Master Program[6] at the Danube University Krems in 2007, an international program for the training of stroke specialists.

Brainin is active in numerous of the WSO's activities. Together with Valery Feigin, he chairs the WSO's Global Policy Committee. He organized and co-chaired numerous international congresses, including the World Stroke Congress in 2020. Throughout his career, he represented the stroke agenda in meetings with the UN and the WHO, often jointly with the World Federation of Neurology, World Heart Federation and World Hypertension League. He is the initiator and supporter of global stroke prevention programs (such as the "Cut Stroke in Half" program). Brainin furthermore advised many countries on the creation and implementation of strategies for stroke treatment, stroke prevention and specialist training (including a training program of 9,000 doctors which he led in Vietnam, as well as other programs in Myanmar, China, Russia and the Philippines). He also supported the founding of the African Stroke Organisation.

His scientific achievements include the development of dysphagia screening, the Gugging Swallowing Screen (GUSS). To harmonize post-stroke care Brainin initiated the development of the Post Stroke Checklist (PSC). A focus of his research was Post-Stroke Cognitive Decline: He initiated and carried out with his team the first randomized polyintervention trial (ASPIS) for the prevention of post-stroke cognitive decline.

Professor Yao received his doctorate degree from Peking Union Medical College in 1999. He has been committed to the diagnosis and treatment of complex and difficult arrhythmias for a long time, and is an international leader in the fields of atrial fibrillation, ventricular tachycardia, sudden death and syncope. The catheter ablation he has completed is the largest series in the world, most of which are patients from all over the country and abroad with various complex and difficult or failed operations in other hospitals.

Due to his academic achievements, he became the first Chinese scholar to give lectures at the International Heart Rhythm Academic Conference, the Ventricular Tachycardia Conference, and the European, American, East Asian, and Southeast Asian Regional Conferences. He has demonstrated surgeries in more than ten countries in Europe, America, Southeast Asia, and South Asia, and has accepted more than 300 specialists from the United States, Britain, Norway, Australia, Japan, South Korea, India, Indonesia, Vietnam, Thailand and other countries to come to China for further study and training. He has also opened a training course for cardiac rhythm specialists from countries along the Belt and Road to help improve their cardiac rhythm diagnosis and treatment level. He has undertaken a number of national 15th, 11th, and 12th Five-Year Plan research projects and multiple international multicenter studies, and presided over a major chronic disease project in the 13th Five-Year Plan. Professor Yao serves as deputy editor-in-chief and editorial board member of many academic journals at home and abroad. Professor Yao is currently the vice chairman of the Chinese Medical Association's Cardiac Rhythm Committee and the vice chairman of the Chinese Society of Biomedical Engineering's Cardiac Pacing and Electrophysiology Branch. He is the chairman of the Asian Heart Rhythm Association (AHRA). He has been awarded the title of National Hundred Thousand Talents, Young and Middle-aged Experts with Outstanding Contributions, and the State Council Special Allowance. He has been selected into the National Health Science Popularization Expert Database.

Vice President of Xuanwu Hospital of Capital Medical University, Director of Interventional Radiology Department, Deputy Director of Neurosurgery Department, Director of Cerebral Revascularization Center, and Director of Strategic Development of National Center for Neurological Diseases. He is also the President of Jinan Hospital of Xuanwu Hospital, Editor-in-Chief of Chinese Journal of Cerebrovascular Diseases, Vice Chairman of Neurointervention Committee of Chinese Medical Doctor Association, Chairman of Neurointervention Expert Committee of Capacity Building and Continuing Education of National Health Commission, Expert of the Sixth Central Health Consultation, Chairman of Stroke Revascularization Committee of Chinese Medical Education Society, etc.

He has won many honors, including "Golden Lancet Award", "Capital Outstanding Young Physician Award", "Beijing Outstanding Physician Award", "Second Prize of Huaxia Medical Science and Technology Award", and "Second Prize of Beijing Science and Technology Progress".

1. Vice Chairman of the Food and Drug Optimization Committee of the China On-site Statistics Research Association
2. Executive Vice Chairman of the Pain Branch of the Chinese Society of Ethnic Medicine
3. Honorary Chairman of the Anesthesia Professional Committee of the China Association of Non-public Medical Institutions
4. Honorary Chairman of the Anesthesia Specialist Branch of the Beijing Medical Association
5. Vice Chairman of the Anesthesia Professional Committee of the China Human Health Science and Technology Promotion Association
6. The 10th Editorial Board of the Journal of Clinical Anesthesiology
7. Chairman of the Pain Physician Branch of the Beijing Medical Association
8. Standing Committee Member of the Neuromodulation Professional Committee of the Chinese Medical Association

Dr. Alraies earned his medical degree from Aleppo University, Aleppo Syria. After completing an internal medicine residency at St. Vincent Medical Center/ Case Western Reserve University, Cleveland, Ohio, he spent the next five years as a staff physician at the Cleveland Clinic, Cleveland, Ohio. During that time, he served as Assistant Professor of Medicine at Cleveland Clinic Learner College of Medicine, where he was involved in teaching and clinical research. Dr. Alraies completed his cardiovascular fellowship training at the University of Minnesota, Minneapolis, MN, where he also received a Master’s of Public Health from the University of Minnesota School of Public Health. Dr. Alraies completed his interventional cardiology fellowship at the Wayne State University / Detroit Medical Center and stayed.

Dr. Alraies has published numerous articles and abstracts in professional, scientific journals, including the Circulation, Journal of American College of Cardiology, American Heart Journal, American Medical Journal, European Heart Journal, Catheterization, and Cardiovascular Interventions and American Journal of Cardiology. His publications focus on topics related to coronary artery disease outcome, coronary interventions, highrisk coronary interventions, cardiogenic shock, and structural heart interventions. He has also written several chapters in medical textbooks related to coronary artery disease interventional and vascular access.

Dr. Alraies has spoken at many major national meetings, workshops, symposiums and conferences about the management of coronary interventions, cardiogenic shock management, and large bore vascular access, as well as digital medical for medical education and social media for medical professionals.

Dr. Atochin received his MD from Siberian State Medical University (Tomsk) and PhD in Institute of Evolutionary Physiology and Biochemistry (St.Petersburg) in Russia. Dr. Atochin was a postdoctoral fellow in the Institute of Environmental Medicine of the University of Pennsylvania and in CVRC of MGH, where Dr. Atochin was promoted to Instructor and Assistant Professor.

Dr. Atochin's research combines mouse genetics, detailed physiologic and hemodynamic measurements, and animal models of human disease, including stroke, atherosclerosis, and diabetes.

Daniel Bereczki is a professor of neurology, chairman of the Department of Neurology, and vice dean of the Faculty of Medicine, Semmelweis University, Budapest, Hungary.  Dr. Bereczki is a board certified neurologist and psychiatrist, with major interest in clinical neurology, especially cerebrovascular diseases. He has gained his clinical and research experience at the Department of Neurology, University of  Debrecen, Hungary;  State University of New York at Stony Brook, USA; and CYRIC Center, Tohoku University, Sendai, Japan. Dr. Bereczki joined the Cochrane Collaboration in 1993, and since 2001 he has been on the Editorial Board of the Cochrane Stroke Review Group.  He also serves on the Editorial Board of the journals Stroke (American Heart Association), Stroke Research and Treatment, Neuropsychopharmacologia Hungarica, and Frontiers in Stroke, and he is a section editor for BMC Neurology. Dr. Bereczki is a consultant for the Medical Research Council, and for the National Health Service, Centre for Reviews and Dissemination (UK), and is the head of the Szentágothai Neuroscience Doctoral School of Semmelweis Universtiy.

Sergio Berti serves as Director of the Cardiovascular Department at Fondazione Toscana Monasterio, Italy. He focusses on percutaneous interventional treatment of structural heart diseases. Previously, he has served as a Full Professor at the School of Cardiology of University of Florence, and as President of the Tuscan Italian Society of Interventional Cardiology. Dr Berti specialises in cardiology, radiology and nuclear medicine. He is widely published in leading peer-reviewed international journals. Dr Berti has served as Principal Investigator and on the steering committees of several leading drug and device-based clinical trials.

Professor of Neurology at the Tel-Aviv University, Sackler Faculty of Medicine.
Chairman of the Israeli Stroke Society (ISS) (since 2019)
Director of the Brain Division at the Shaare-Zedek Medical Center (since 2016)
Head of Stroke Unit at the Tel-Aviv Medical Center (1989-2016)
Chairman of the ESNCH (2013-2017)
Chairman of the Israeli Neurological Association (since 2008-2017)
Vice President of the World Stroke Organization (WSO) (2008-2018).
Chairman of Neurology Department, Tel-Aviv Medical Center (2002-2007)

Consulting Editor of Stroke
Editorial Board CVD, EjoN, Acta Neurologica Scandinavica, International Journal of Stroke, Neurosonology, Frontiers in Stroke, Journal of Annals of Medical Science.
Fellowship program in vascular neurology (stroke) in Toronto, Canada with Prof. John Norris( 1984-87)
Main research interests are: Epidemiology of stroke, Stroke prevention, Vascular dementia, Inflammation and stroke, Neurosonology.

Simone Calcagno, based in Civitavecchia, IT, is currently a Caridologo interventista at Ospedale San Paolo Civitavecchia. Simone Calcagno brings experience from previous roles at GVM Care & Research, Ospedale Santa Maria Goretti, Policlinico Umberto I and Ospedale Civile di Ivrea ASLTO4. Simone Calcagno holds a 2010 - 2020 Dottorato di ricerca in Fisiopatologia Cardiorespiratoria @ Sapienza Università di Roma.

Cao Yong, Chief Physician, Professor, Doctoral Supervisor, Postdoctoral Fellow at the University of California, San Francisco, Executive Deputy Director of the Neurosurgery Centre, Director of Cerebrovascular Surgery Ward 1, Secretary of the Joint Party Branch of Cerebrovascular Surgery Wards 1-2. Deputy Director of the Capital Medical University Brain Major Disease Research Institute, Deputy Director of the Cerebrovascular Disease Group of the Chinese Medical Association Neurosurgery Branch, Chairman of the Chinese Stroke Society Composite Interventional Neurosurgery Branch.

Prof Valeria Caso is a consultant neurologist at the stroke unit of Santa Maria della Misericordia Hospital at the University of Perugia, Italy. 
She earned her medical degree from the University of Perugia. She specialised in neurology with exceptional distinction, achieving a score of 50/50 with honours. She also enriched her knowledge as an Erasmus research fellow at esteemed institutions such as Christian Albrecht University in Kiel, the University of Heidelberg, and the University of Zürich.

Her research endeavours have encompassed diverse areas and include participating in 20 multicentre trials in various capacities, including steering committees. She actively engages in international research initiatives on heart-brain interactions, intracerebral hemorrhage, and acute stroke treatment.
She has Italian national certification as a full professor in neurology and is acknowledged as a visiting professor in neurology at the University of Belgrade.
She has served as president of the European Stroke Organisation (2016-2018) and as past president and co-chair of the European Stroke Action Plan (2016-2018). She also contributes her expertise as a member of the ESO-EAST Steering Committee and as a Founding Member of “Osservatorio Ictus Italia”. 

She is an honorary member of the Société Française Neuro-Vasculaire (SFNV) and has held the position of treasurer at the World Stroke Organization since 2022.
Her numerous awards include an ESO Spirit of Excellence Award in 2020, and the ESO Presidential Award in 2022. 
She has published more than 300 articles. Her h-index is 70 (17517 Google Scholar citations).

Current position:
- Currently Professor, Department of Medicine, National Yang Ming Chiao Tung University
- Currently Director, Department of Neuroradiology, Department of Radiology, Taipei Veterans General Hospital
Experience:
- Adjunct Associate Professor, Department of Medicine, National Yang Ming Chiao Tung University
- Director, Department of Pediatrics and Emergency Radiology, Department of Radiology, Taipei Veterans General Hospital
- Adjunct Assistant Professor, Department of Medicine, National Yang Ming Chiao Tung University
- Attending Physician, Department of Neuroradiology, Taipei Veterans General Hospital
- Resident/Chief Physician/Attending Physician, Department of Radiology, Taipei Veterans General Hospital
- University of New York at Buffalo Neurosurgery Intern
- University of Toronto Children's Hospital Neuroradiology Trainee Doctor

Dr. Jun Chen is currently an assistant professor in the Department of Bioengineering at the University of California, Los Angeles. His research focuses on soft matter innovation for novel bioelectronics and personalized healthcare.

He has published two books and 300 journal articles, with 200 of them being corresponding authors in Chemical Reviews (2), Chemical Society Reviews (2), Nature Review Bioengineering (1), Nature Materials (2), Nature Electronics (6), Nature Biomedical Engineering (1), Nature Communications (6), Science Advances (3), Joule (3), Matter (12), Advanced Materials (12), among others.

He also filed 14 US patents, including one licensed. With a current h-index of 108, Dr. Chen was identified to be one of the world’s most influential researchers in the field of Materials Science in the Web of Science. Beyond research, he is an associate editor of Biosensors & Bioelectronics, Med-X, FlexMat, Textiles, and VIEW Medicine, Advisory/Editorial Board Members of Matter, Cell Reports Physical Science, Materials Today, Materials Today Energy, Nano-Micro Letters, Nano Trends, The Innovation, among others.

Among his many accolades are the V. M. Watanabe Excellence in Research Award, UCLA Faculty Mentor Award, UCLA Society of Hellman Fellows Award, Georgia Tech Alumni 40 Under 40, Shu Chien Early Career Award, ONR Young Investigator Award, AHA Innovative Project Award, AHA Transformational Project Award, AHA's Second Century Early Faculty Independence Award, NIH UCLA CTSI KL2 Translational Science Award, BBRF Young Investigator Award, Okawa Foundation Research Award, Advanced Materials Rising Star, Materials Today Rising Star Award, ACS Nano Rising Stars Lectureship Award, Chem. Soc. Rev.

Emerging Investigator Award, Nano Research Young Innovator Award, ACS PMSE Young Investigator Award, Clarivate Highly Cited Researchers 2019/2020/2021/2022/2023, among others.

Academic Appointments
Instructor, Neurosurgery

Honors & Awards
Postdoctoral Fellowship, American Heart Association (01-01-2022)
Young Investigator Award, 13th International Symposium on Healthy Aging (03/2018)
Best Oral Presentation, The 8th Symposium for Cross-straits, Hong Kong and Macao on Free Radical Biology and Medicine (09/24/2018)
Travel Award, 2018 World life Science (10/29/2018)
Ph.D. studentship, University of Hong Kong (2011-2015)

Boards, Advisory Committees, Professional Organizations
Member, Society for Neuroscience (2021 - Present)
Member, American Heart Association (2021 - Present)

Member of the Tumor Professional Group of the Peripheral Nerve Committee of the Chinese Medical Association
Member of the Neural Regeneration and Restoration Professional Committee of the Chinese Association of Research Hospitals
Young member of the Neurosurgery Branch of the Shanghai Medical Association, and deputy leader of the Craniocerebral Trauma Group
Young member of the Trauma Branch of the Shanghai Medical Association
Member of the American College of Neurological Surgeons (CNS)
Member of the International Brain Injury Association (IBIA)
Expert in teaching the online courses of the International Neurosurgery Education and Training Series
National Natural Science Foundation Project Correspondence Review Expert
Editorial Board Member of Experimental and Therapeutic Medicine and Brian & Heart
Young Editorial Board Member of Journal of Neurorestoratology and Advanced Technology in Neuroscience
Review Expert of CNS Neuroscience & Therapeutics and Neural Regeneration Research

Senior assistant professor (fixed-term) at the University of Bologna since 2024. Clinical activity conducted at the Cardiology Unit of the Morgagni-Pierantoni Hospital, Forlì. The research activity is mainly aimed at coronary and structural interventional cardiology. He participates in multicenter research projects and he is the author of many publications in peer-review journals.

Sam is a NHMRC Senior Research Fellow, head of the Epigenetics in Human Health and Disease lab and is internationally recognised with more than 200 articles published in journals like Circulation and Circ Res, JCI, Eur Heart J, Nucleic Acids Res, Signal Transduct Target Ther, Nat Comm, Regen Med, Diabetes, Sci Adv, Cell Rep and JCI Insight. 

Sam has developed a training program for early career scientists (ECS) in the technologies critical for epigenetics research with a major objective supervision of local and international students. He is an Adjunct Professor with the Chinese University of Hong Kong, Honorary at University College Copenhagen and committed to gender, equity, diversity and inclusion for international ECS. He serves as editor and on editorial boards, an international programs advisor, and as committee chair, promoting new scientific areas and contemporary program themes for major meetings. He has developed a training program for PhD students in the major technologies critical for contemporary epigenetic research and a major objective is his supervision of national and international scientists. Sam is currently on assignment in Denmark with the Danish Diabetes Academy (DDA) professorship with the Steno Diabetes Centre Copenhagen (SDCC).

The purpose of the Epigenetics in Human Health and Disease lab is to close the existing clinical gap in human data as it pertains to epigenetics and diabetic complications. Combined with contemporary molecular approaches that lead to gene target identification our work will pinpoint regulatory targets that will have international outreach. This research will also see major improvements in rational drug design and advance Australia’s international reputation for excellence in medical epigenetics.

Dr. Francisco Epelde Gonzalo a specialist in Internal Medicine, Master in Ischemic Heart Disease from the Central University of Barcelona (UB), Master in Hospital Management from the UB, Master in Cardiovascular Diseases from the UB, Master in Patient of Advanced and Pluripatological Age from the UB, Master in clinical Management from the Catholic University of Murcia.

Dr. Francisco Epelde Gonzalo is Currently Medical Coordinator of the Short Stay Unit of the Parc Taulí de Sabadell University Hospital and Coordinator of the Emergency Working Group of the Spanish Society of Internal Medicine. 

Dr. Francisco Epelde Gonzalo is an associate professor of the Department of Medicine of the UAB, where he is responsible of Emergency Medicine. He has been anexternal consultant in emergency medicine at WHO. Author of 250 publications and 7 book chapters.

Dr. Feng has more than 30 years of experience working in academic institutions. His research interests range from understanding fundamental rules of life and disease to translational biomedicine. Dr. Feng has expertise in structure-function of G protein-coupled receptors, signal transduction, regulation of gene transcription and splicing, generation of iPSCs and stem cell homing,  genome and epigenome editing, drug screening and discovery, exosome, mRNA synthesis and delivery. He applied his expertise to study pathogenesis and treatment strategy for cancer, metabolic diseases, neurodegenerative diseases, cardiovascular diseases, depression, and inherited diseases. Some results from Dr. Feng’s laboratory were published in many peer-reviewed journals and applied for patent protection.

Dr. Feng was a distinguished professor of Wuhan University School of Medicine and Guangzhou Medical University in China. He served as a grant reviewer for many national foundations of USA, China, and South Africa. He has been members of many professional societies such as ASPET and ASBMB, and editorial board of many professional journals such as Biochemical Pharmacology.

Dr. Feng received his medical degree from Wuhan University School of Medicine, PhD in Biochemistry and Molecular Biology from University of Oxford. He completed his postdoctoral training in Molecular Cardiology at Cleveland Clinic.

Dr. Feola is an Italian Cardiologist and he is the Director of the Cardiology Division in the Hospital Regina Montis Regalis in Mondovi' (Italy). Mondovi' is a lovely city in the North-West of Italy, near the Mediterrean SEE and near beatiful mountains. The field of interest were the same for many years: heart failure and cardiovascular imaging.

Dr. Alfio Ferlito is Formerly Director of the Department of Surgical Sciences at the University of Udine School of Medicine from 2003 to 2009 and Professor and Chairman of the ENT Clinic at the same University from 1997 to 2013. He graduated in medicine at the University of Bologna in 1968. He completed his residency programme in Otolaryngology and subsequently in pathology. He worked at the ENT Department of Padua University from 1970 to 1997. Since 2009 he is the Coordinator of the International Head Neck Scientific Group.

Dr. Alfio Ferlito received many honors and awards during his career.  He served as editor, co-editor, assistant editor or reviewer for the 736 journals. He has collaborated in writing articles, editorials, commentaries, letters to the editor, special issues, book chapters and books with 665 international experts. He has edited a three-volume book entitled Cancer of the Larynx (CRC Press, Boca Raton, 1985) and three other books entitled Neoplasms of the Larynx (Churchill Livingstone, Edinburgh, 1993), etc. He is Editor of four issues of ORL Journal for Oto-Rhino-Laryngology, Head and Neck Surgery. He has been author and co-author of 657 referred publications in 70 medical journals and 54 chapters in various books. He is a fellow or a member of the many societies. He collaborated as a member of the World Health Organization’s Committee on Histological Typing of Tumors of the Upper Respiratory Tract and Ear. He is also a member of the Laryngeal Cancer Association’s Committee on the Classification of Laryngeal Cancer. He was a consultant to Yale University. He was a consultant to Yale University. He has delivered prestigious lectures all over the world. In 2006 he gave the 2nd Morrison Lecture in San Francisco and the 19th Som Lecture in New York. He has divided his professional life between clinical practice, teaching and research.

Prof Seana Gall is an epidemiologist that studies the risk factors and outcomes for heart disease and strokes.

As a cardiovascular epidemiologist, she works with large sets of data and looks for answers to important questions like: what is the frequency of a particular disease and how is that frequency changing over time? Are there groups within the population that suffer higher rates of the disease? What are the factors that make these diseases more or less likely? And what are the factors that affect the outcomes of treatment?

One area of Prof Gall’s research is to examine the factors that put certain groups within the population at a higher risk of heart disease and stroke. Overall, statistics have shown a gradual decline in the incidence of stroke and heart disease. However, among some groups such as young people and women, this trend has levelled off in recent years and even shifted into reverse.

‘Understanding the factors driving these trends will allow us to develop better approaches to disease prevention,’ Prof Gall says. ‘This might include better and more targeted education about the risk factors and designing more effective programs or policies for early intervention to prevent strokes and heart disease.’

In her research, Prof Gall draws on several large cohort studies. This includes the Childhood Determinants of Adult Health study (CDAH) – an Australia-wide study that follows up on people first assessed when they were at school in 1985. ‘The CDAH study allows us to take a life-course approach and investigate the importance of childhood factors in the later development of risk factors for heart disease and stroke, factors like weight, diet, physical activity and smoking.

‘As an epidemiologist, I find Tasmania is a particularly good place to do this kind of work,’ Prof Gall says. ‘Being an island state means it is easier to keep track of people over the course of a long-term study. Also, unfortunately, some of the risk factors we are studying are particularly prevalent in Tasmania.’

A large part Prof Gall’s research is investigating how to prevent stroke, which happens when the blood supply to the brain is stopped. 'Stroke is a large cause of death and ill health in Tasmania' Prof Gall says. 'It can happen to people of any age but it is preventable, with up to 8 out of 10 strokes thought to be preventable by managing the risk factors for stroke like high blood pressure or smoking' . She is currently leading Australia’s first research program dedicated to stroke prevention – Synergies to Prevent Stroke (STOPstroke) – funded by the National Health and Medical Research Council’s Synergy Grant program for $5 million over 5 years. Prof Gall and her team of collaborators across Australia and New Zealand are searching for new ways to prevent strokes. 'We are running several studies to develop and test new ways to help people know and manage their risk factors for stroke. We are also working with people that have had a stroke to find better tools and programs so that people can lower their risk factors and stop them having another stroke' says Prof Gall. 

Prof Gall’s wide expertise has seen her appointed to several public health bodies. She chairs the Tobacco Control Coalition – a Tasmanian government initiative that also involves NGOs – that is responsible for developing the state’s tobacco control plan, including setting goals and priorities, developing plans and overseeing the implementation of those plans. She is a member of the Australian Institute of Health and Welfare's Cardiovascular Disease Expert Group.

Dr. Giribabu Nelli is an Associate Professor of Physiology at Universiti Malaya, Malaysia, with expertise in reproductive endocrinology, diabetes, obesity, and natural products. His strong academic background includes a PhD from Sri Venkateswara University, Andhra Pradesh, India) and an M.Sc. from Sri Venkateswara University, India.

His prolific research career is marked by over 77 ISI-indexed publications, 5 book chapters, and three patents, demonstrating significant contributions to reproductive biology and pre-clinical research. This impactful work is further evidenced by substantial grant funding secured as both principal and co-investigator, totalling nearly RM 2.5 million.

A dedicated mentor, Dr. Nelli has successfully supervised 4 PhD and 7 Masters students to completion, fostering the next generation of researchers. His contributions extend to his leadership roles as Academic Editor for prestigious journals such as PLOS ONE, the International Journal of Endocrinology, Frontiers in Endocrinology, and Frontiers in Physiology and Associate Editor for the European Journal of Medical Research.

Dr. Nelli's international recognition is highlighted by numerous invited talks at prominent conferences, showcasing his expertise in personalised medicine for endocrine disorders. His leadership is further exemplified by his role as Co-Chairman of the International Conference on Reproductive Science & Medicine. His research consistently bridges preclinical and translational studies, establishing him as a key figure in personalised drug discovery.

His impressive career at Universiti Malaya encompasses various academic and administrative roles, including coordinating elective courses and serving as an academic advisor for MBBS students. His dedication and excellence are recognised through the University Malaya Excellent Service Award (APC) in 2018, 2019, and 2021, and the Excellent Service Certificate (SPC) in 2022. He currently serves as President of the Society of Phytopharmacology and Research.

Chief physician of surgery at the First Affiliated Hospital of Zhengzhou University. Nationally renowned expert, doctoral supervisor, professor/chief physician, director of neurosurgery at the South Campus of the First Affiliated Hospital of Zhengzhou University, expert who returned from the United States. Host of national key research and development projects, director of the "Henan International Joint Laboratory for Nervous System Malformations". Review expert of major projects of the Ministry of Science and Technology and National Natural Science Foundation projects, review expert of postgraduate thesis of the Ministry of Education of the People's Republic of China, and leader of scientific and technological innovation of the Henan Provincial Health Commission.

Medical expertise: Doctor of Medicine, Associate Chief Physician, Master Supervisor. Mainly engaged in the research of chronic kidney disease and its complications, and peritoneal dialysis.

Research direction: chronic kidney disease and its complications, peritoneal dialysis

Main education and work experience: Obtained a Doctor of Medicine degree from Sun Yat-sen University of Medical Sciences in 2001. In 2008, he was funded by the National Scholarship Fund to study at the Institute of Nephrology of Karolinska Institute in Sweden.

Publications: He presided over 4 scientific research projects, including 1 National Excellent Doctoral Dissertation Author Fund, 1 Fok Ying-Tong Fund, and 1 Guangdong Provincial Science and Technology Plan Project. He has published more than 20 papers in important academic journals at home and abroad; 7 papers included in SCI, including 4 as the first author. He has presented papers at international academic conferences many times.

Other major work achievements (such as awards): Won the honors of "National Excellent Doctoral Dissertation" and "South Guangdong Excellent Postgraduate". He has supervised 1 master's student.

Dr. Teruhiko Imamura is an Associate Professor at the Second Department of Medicine, University of Toyama in Japan. His research keywords and expertise include Heart Failure, Heart Transplant, Hemodynamics, Valvular Heart Disease and Mechanical Circulatory Support. 

PhD from Peking Union Medical College, associate researcher in neurology, doctoral supervisor, and national "Excellent Young Scientist".
In 2014, he went to the Barrow Neurological Institute of St. Joseph's Hospital and Medical Center in the United States to do postdoctoral work. Since 2018, he has worked at Beijing Tiantan Hospital and the director of the office of Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases.
Her academic part-time jobs include serving as a director of Tianjin Stroke Society, a member of the Translational Medicine Branch of the Chinese Stroke Society, a member of the Neuroimmunology Branch of the Chinese Medical Association, and an executive director of the Youth Council of the Chinese Stroke Society.

Ulf Dietrich Kahlert is a German cancer researcher and stem cell biologist. He is a professor at the Medical Faculty of the Otto-von-Guericke University Magdeburg (OvGU), where he leads the Department of Molecular and Experimental Surgery at the Clinic for General, Visceral, Vascular, and Transplant Surgery.

Starting in October 2015, he led the Translational Neurotechnologies group at the Clinic for Neurosurgery at the University Hospital Düsseldorf. In November 2020, he habilitated at the Medical Faculty of the University of Düsseldorf on the topic of stem cell technology for precision oncology and received Venia Legendi. In April 2021, he accepted a professorship for Molecular and Experimental Surgery at OvGU. Since 2023, he has been the head of Molecular Research at the AN-Institute for Quality Assurance in Operative Medicine at OvGU. His research group participates in the STIMULATE campus, a public-private partnership focused on the development of modern medical technology. In 2024, he was appointed chairman of the Magdeburg local group of the German Association of University Professors and Lecturers and chairman of the Commission for International Relations of the Faculty of Medicine at OvGU.

Dr. Chunsheng Kang is Professor and Vice-director at Lab of Neuro-oncology, Tianjin Neurological Institute, Department of neurosurgery, Tianjin Medical University General Hospital, P. R. China. He is a member of many professional societies, including American Association for Cancer Research and Chinese Neurosurgical Society. He is also a vice board chairman of Tianjin Genetics Society. Dr. Kang received his bachelor degree in medicine from Tianjin Medical University, P. R. China in 1993 and his Ph.D. in neurosurgery from Tianjin Medical University General Hospital, Tianjin, P. R. China in 2003. He specializes in RNAi in cancer, microRNA and signaling pathway in cancer, high-throughput analysis in cancer, nonviral gene delivery system. His research has received sustained funding from the Chinese Natural Science Foundation, 'Program for New Century Excellent Talents in University” of Ministry of Education, Natural Science Foundation of Tianjin Municipal Science and Technology Commission and other foundations. Dr. Kang has supervised the research efforts of over 30 postdoctoral associates, doctoral candidates and master’s level graduate students in the past 8 years.

Deputy Director on Science and Technology, National Medical Research Center for Therapy and Preventive Medicine, Moscow, Russia.

[part-time] Professor, Department of Dynamic Modeling and Biomedical Engineering, Faculty of Nano- and Biomedical Technologies, Saratov State University, Saratov, Russia.

[part-time] Director of LLC Science and Innovations, Saratov, Russia.

Dr. Vinay Kumar holds a master's degree in biotechnology from Himachal Pradesh University, Shimla, India, as well as a PhD in Molecular Biology and Genetic Engineering from Jawaharlal Nehru University, New Delhi, India. Presently at Pennsylvania State University, he conducts thorough studies of dysregulated innate and adaptive immunological networks and their function in modulating the pathophysiology of myocardial infarction (MI) and chronic heart failure (HF).

Dr. Kumar is especially interested in determining the function of T-cell subsets and the time-dependent phenotypic changes that these cells endure during chronic HF. In addition, he is interested in identifying and devising novel strategies to reverse pathological changes in immune cells in preparation for their transition from the laboratory to the clinic. His training in physiology, immunology, and molecular biology equips him with unique perspectives to research heart failure and develop mechanism-based, clinically applicable immune-therapeutic strategies.

Full Professor of Advanced Medical and Surgical Technical Sciences, University of Catania, Italy

Consultant Neurologist & Chief, Clinical Neurophysiology Research Unit, Oasi Research Institute‑IRCCS (a WHO Collaborating Centre), Troina, Italy

Assistant Professor (Senior Academic Researcher), University of Catania

Visiting Clinical Research Fellow, Department of Neuroscience & Clinical Neurophysiology, Newcastle University, UK

Scientific Fellow selected by the European Federation of Neurological Societies (EFNS), 2013

International award for translational research in sleep medicine

Dr Zhe Kang Law, born 1982, is a consultant physician/neurologist and associate professor at the National University of Malaysia, Kuala Lumpur, Malaysia.

Training: He graduated from medical school, National University of Malaysia in 2007, passed Membership of College of Physicians, MRCP(UK) exam in 2011 and completed a Malaysian neurology subspecialty training programme in 2016. In 2019, he completed a PhD in Stroke Medicine at the University of Nottingham, United Kingdom under the supervision of Professors Nikola Sprigg and Philip Bath. Between 2019 to 2021, he undertook a post-doctoral fellowship at the Lewy Body Lab, Newcastle University, UK, before returning to Malaysia in June 2021.

Research areas: His main research focus is on intracerebral haemorrhage. For his PhD thesis, he worked on data from the Tranexamic acid in IntraCerebral Haemorrhage-2 (TICH-2) randomised controlled trial. He was the Malaysian national coordinator of TICH-2 and currently ongoing Tranexamic acid for hyperacute spontaneous IntraCerebral Haemorrhage-3 (TICH-3) randomised controlled trial. He was also involved as an investigator/ trial physician for several stroke randomised controlled clinical trials, including RIGHT-2, RESTART, SOSTART, RESTORE brain, LACI-1, ATTEST-2, TASTE, TWIST, WAKE-UP and TRIDENT. 

Awards: He was awarded the Young Investigator Award 2021 by the Malaysian Stroke Council. He also won the Hoff’s Award for best oral abstract in 2017 World Intracranial Haemorrhage Conference, and institutional excellent clinical service award in 2016, and excellent publication award in 2018 and 2020. He also won the Malaysian Society of Neurosciences best publication award for 2020 and 2022.

Professional: He is a member of World Stroke Organisation, European Stroke Organisation, Malaysian Stroke Council, Malaysian Society of Neurosciences and Malaysian Academy of Medicine. He is a Fellow of Royal College of Physicians (Edinburgh). He is a member of editorial board for European Stroke Journal and an associate editor for Neurology Asia. He is a reviewer for several stroke/neurology journals including European Stroke Journal, Stroke and Vascular Neurology, Translational Stroke Research, International Journal of Stroke, Cerebrovascular Diseases, Neurology Asia, Frontiers in Neurology, BMJ Open and Thrombosis Research. He has given platform presentations in local and international conferences including in European Stroke Organisation Conference, World Stroke Congress, UK Stroke Forum and Malaysian Stroke Conference.

Publications: He has authored 64 journal articles to date including in the Lancet, European Stroke Journal, Stroke, International Journal of Stroke, Translational Stroke Research, Cochrane Systematic Reviews, JNNP and JAMA Neurology. His h-index is 16 (google-scholar citations). He is also a member of the evidence reviewer team for the 6th National Clinical Guideline for Stroke for the UK and Ireland, which is currently being drafted. He is coordinating the first Malaysian guideline on management of intracerebral haemorrhage.

In Private: He is happily married to Swee Wei, a lung transplant physician, to whom he provides statistical service on occasions. They have a 9-year-old daughter and a 6-year-old son. He is a chess fanatic and dreamt of becoming a chess grandmaster before he took up a medical career. 

Dr. Djamel Lebeche, PhD, FAHA, FACC, is currently a Professor at the Department of Physiology, a Graduate Faculty at the College of Graduate Health Sciences, and a member of the neuroscience Institute at The University of Tennessee Health Science Center. Dr. Lebeche graduated from the department of Physiology at Boston University School of Medicine where he received his Master and PhD degrees in Molecular Physiology. After completing his post-doctoral training at Massachusetts General Hospital/Harvard Medical School/Boston, he was appointed as an instructor in Medicine at Harvard Medical School before assuming Assistant and then Associate Professor positions at the Cardiovascular Research Center at Mount Sinai School of Medicine, NY.
Dr. Lebeche primary research interests focus on the molecular mechanisms and signaling pathways contributing to the pathophysiology of hypertrophy and heart failure, with a particular emphasis on the pathogenesis of diabetic cardiomyopathy and cardiometabolism, understanding the pathophysiology of the disorders as well as response to various established and newly discovered therapies. We utilize multidisciplinary approaches ranging from discovery science in patient biological samples to mechanistic studies in cell-based systems, transgenic mice, and animal models of heart failure. Our aim is to provide new insights into the genetic, epigenetic, and cellular mechanisms that regulate diabetic heart failure and risk of metabolic diseases with an eye toward genetic and pharmacological therapeutic interventions. A second research focus involves discovering novel small molecules suitable for clinical development as novel therapeutical agents to treat heart failure, diabetes, and other metabolic diseases. The long-term scientific goal is to explore new targetable pathologic genes and relevant drugs that have significant clinical and curative impact on metabolic cardiomyopathies. As a means to this end, our work has thus far uncovered for the first time the importance of a paradigm for the antagonistic crosstalk between calcium homeostasis and adipokines bioactivity in cardiac metabolism and patho-function, and the discovery of small molecules/drugs that provide protection against glycemia intolerance and metabolic disorders in vivo. These novel compounds have demonstrated strong therapeutic potential in type 2 diabetes in pre-clinical animal studies and therefore will be invaluable to treat diabetes and its metabolic and cardiovascular complications. Our functional cardiovascular genetic studies have led to major findings related to syndromic variants causing different human dilated cardiomyopathy and hypertrophic cardiomyopathy phenotypes.
Dr. Lebeche’s research has been supported by grant awards from the national Institutes of Health (NIH), the Juvenile Diabetes Research Foundation and other sources. Dr. Lebeche is a member of a number of professional societies and served as a reviewer for NIH, the DoD and many national and international associations and foundations. He is currently an editorial board member of Nature Scientific Reports. In addition to his research activities, Dr. Lebeche has a passion for mentoring and training the next generation of cardiovascular scientists.

Doctor of Neurology, Chief Physician. Director of the Department of Neurology, Fuwai Hospital, Chinese Academy of Medical Sciences. Mainly engaged in the treatment of acute and critical cerebrovascular diseases: thrombolytic therapy for acute cerebrovascular diseases and monitoring and treatment of complications in critically ill patients. Visiting scholar at the Neurology Center of the Royal Melbourne University, Australia, and the OSF/INI Comprehensive Stroke Center in Beacon, Illinois, USA. Also serves as Vice Chairman of the Youth Council of the Chinese Stroke Society, Vice Chairman of the Medical Quality Management and Promotion Branch of the Chinese Stroke Society, and Supervisor of the First Supervisory Board of the Chinese Stroke Society.

Professional expertise: Prevention, diagnosis and treatment of various acute and chronic cerebrovascular diseases, especially cardiogenic stroke. Comprehensive treatment of neurological critical illness. Diagnosis and treatment of dizziness, headache, Parkinson's disease, and cognitive dysfunction.

Dr. Liu currently served as Professor of Cardiology in Tianjin Medical University; Deputy director of Tianjin Institute of Cardiology and an electrophysiologist in Department of Cardiology, Second Hospital of Tianjin Medical University, 300211, Tianjin, P.R. China. His current interests concern the study of atrial fibrillation and arrhythmias. Secondly. He also participate in some researches in the field of Cardio-oncology and heart failure. Furthermore, He has participated in several clinical research protocols that cover a wide range of issues in Cardiology and Internal Medicine. He has published more than 200 papers in Peer-reviewed medical journals, including 110 papers with first/co-first/corresponding/co-corresponding authors. 

Dr. Liu holds position in Chinese Medical Association in the field of cardiology. He mainly focuses on arrhythmia, especially atrial fibrillation and sudden cardiac death. He received training abroad and studied cardiac diseases.

As one of the most experienced surgeons in the field of arrhythmia in China, he has completed more than 5000 cases of interventional therapy for various kinds of arrhythmia until now.

Brandon Lucke-Wold was born and raised in Colorado Springs, CO. He graduated magna cum laude with a BS in Neuroscience and distinction in honors from Baylor University. He completed his MD/PhD, Master’s in Clinical and Translational Research, and the Global Health Track at West Virginia University School of Medicine. His research focus was on traumatic brain injury, neurosurgical simulation, and stroke. At West Virginia University, he also served as a health coach for the Diabetes Prevention and Management program in Morgantown and Charleston, WV, which significantly improved health outcomes for participants. In addition to his research and public health projects, he is a co-founder of the biotechnology company SwiftScience, the pharmaceutical company ProPhos Neuroscience, and was a science advocate on Capitol Hill through the Washington Fellow’s program.

He has also served as president of the WVU chapters for the American Association of Pharmaceutical Scientists, Neurosurgery Interest group, and Erlenmeyer Initiative Entrepreneur group. In addition, he has served as vice president for the graduate student neuroscience interest group, Nu Rho Psi Honor Society, and medical students for global health. He was an active member of the Gold Humanism Honor Society and Alpha Omega Alpha Honor Society. He is currently Vice President of the UF House Staff Council, Chair of the Quality Improvement Committee, on the Board of Directors for the Alachua County Medical Society, and active member of Institutional Review Committee and Accreditation Requirements Review Committee. He is married to Noelle Lucke-Wold and has two children.  As a family, they enjoy running with their dogs, rock climbing, and traveling.  In his spare time, Brandon frequently runs half marathons and 10ks together with is wife. Brandon also enjoys reading, playing piano, discussing philosophy, and playing chess. He is currently a Pgy6 neurosurgery resident at University of Florida with pursuing endovascular enfolded training and was awarded the Dempsey Cerebrovascular Research Fellowship, SNS Fellowship, Van Wagenen Fellowship, R25 Grant, and SNIS Fellowship.

Dr. Saurav Mallik is currently working as Research Scientist in the Department of Pharmacology and Toxicology, The University of Arizona, USA. Previously, he worked as Postdoctoral Fellow in the Department of Environmental Health, Harvard T H Chan School of Public Health, Boston, USA for more than three years (2019-2022), the Center of Precision Health, Department of School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, Texas, USA for one and half year (2018-2019), and in the Division of Bio-statistics, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA for more than one year (2017-2018).  He obtained his PhD degree in the Department of Computer Science & Engineering (C.S.E.) from Jadavpur University, Kolkata, India in 2017 while his PhD works carried out in Machine Intelligence Unit (MIU), Indian Statistical Institute (ISI), Kolkata, India. He worked previously at ISI, Kolkata, India as a Junior Research Fellow (JRF) in DST (Department of Science & Technology, New Delhi, Govt. of India)-sponsored Swarnajayanti project and as a Visiting Scientist (VS) for a total of more than 3 years (2011-2013 & 2015-2016). He also worked in the Department of Computer Science & Engineering, Jadavpur University, Kolkata, India as UGC (University Grant Commission, Govt. of India) Research Fellow for 2 years (2014-2015 & 2016-2017). He is the recipient of Research Associate-ship (RA) from CSIR (Council of Scientific and Industrial Research), MHRD, Govt. of India in 2017. He also worked as assistant professor in the Department of Computer Science & Engineering in Mallabhum Institute of Technology, Bisnupur, WB, India (currently on leave). He is also recipient of "Emerging Researcher In Bioinformatics" award from Bioclues & BIRD Award steering committee, India (http://bioclues.org/) in the year 2020 and "Young scientist award" on “International Scientist Awards on Engineering, Science and Medicine" (ISAO 2021) from a non-profit organization, VDGOOD Professional Association of Scientists, Engineers and Doctors, India in the year 2021. He received two times Travel Grant Award for International Conference on Intelligent Biology and Medicine (ICIBM), June 2018 at Los Angeles, California, USA and August 2021 at Philadelphia, PA, USA. Dr. Mallik has coauthored more than 180 research papers in various peer-reviewed International Journals, Conferences and Book Chapters. He also has more than 20 authored/edited book publication in Taylor & Francis, River publishers, IET, Springer, Bentham, etc. His papers are highly cited (google scholar citation >1850 and h-index=22). He attended many national and international conferences in USA and India. He is currently an active member of Institute of Electrical and Electronics Engineers (IEEE), American Association for Cancer Research (AACR), and Association for Computing Machinery (ACM), USA and life member of BIOCLUES, India (http://bioclues.org/). He is also member of international advisory committee of many reputed engineering colleges in India. His research areas include Data mining, computational biology, bioinformatics, Bio-statistics and machine learning.

Giuseppe Mancia is Professor Emeritus at the University Milano-Bicocca, after serving for 20 years as Chairman of the Division and Department of Internal Medicine at the same university at the San Gerardo Hospital in Monza and Director of the Interuniversity (Universities of Milano, Milano-Bicocca, and Pavia) Center for Clinical Physiology and Hypertension. He was Chairman (2001, 2003, 2005, 2007, 2009, 2011, 2013, and 2017) of the Scientific and Organizing Committee of ESH meetings, and is a past President of the International Society of Hypertension (ISH), European Society of Hypertension (ESH), European Society of Clinical Investigation, and Italian Society of Hypertension. He chaired the Task Force of the ESH/ESC Hypertension Guidelines in 2003, 2007, 2009, 2013 and 2018. Professor Mancia is currently Chairman of the ESH Foundation. He is an honorary member of several hypertension and cardiovascular societies and has received many awards, including the Excellence Research Award of AHA, the Heymans Award of the International Society of Pharmacology, the Volhard and Tigersted Awards of the ISH, the Folkow Award of the ESH, the International Recordati Prize, the Invernizzi Prize for Medicine, the Spinoza Honorary Professorship of the University of Amsterdam, the Gold Medal of the Lorenzini Foundation, an Honorary Professorship of the University of Córdoba, an Honoris Causa Doctorate in Medicine from the University of Gdansk, Bucharest (Carol Davila), and Glasgow, the Hariri Memorial Lecture and Award, the MacDonald Award of McMaster University (Hamilton) and the Cleveland Clinic Lecture. Professor Mancia’s research focuses on the epidemiology, pathophysiology, diagnosis, and treatment of hypertension, heart failure, coronary and other cardiovascular diseases. He has edited more than 20 books on hypertension and cardiovascular diseases and published more than 2400 articles in peer review international journals. His articles have received more than 240,000 citations (H-index 182, Microsoft Academics, December 2021).He has been Deputy and Chief Editor of the Journal of Hypertension (1995-2021)

Dr. Martins was graduated in Medicine (Universidade Federal do Rio Grande do Sul), has Residence in Neurology, PhD in Stroke Neurology and specialization in organization of public health networks by the Ministry of Health (MOH) of Brazil. She is the founder and President of the Brazilian Stroke Network. In 2008, as advisor of the MOH, started the organization of the National Stroke Policy published in 2012. In 2020, published in New England Journal a Brazilian MOH clinical trial of thrombectomy in stroke in public hospitals, the first study proving that the treatment is feasible, effective and cost-effective in developing countries. This study changed the national stroke policy. In 2021 started the implementation of a World Stroke Organization (WSO) program together with the MOH: primary prevention for stroke based on a polypill associated with life style modification.
She has large experience as clinician in public health, and also as health manager working together with different levels of governments, helping the implementation of strategies to improve public health care in stroke.
She is helping other countries and in 2021 launched the Certification of Stroke Centers in Latin America in 11 countries.
She is WSO member since 2008 and now is the President (2024-2026).

Dr. Jose Carlos Pachon Mateos is currently Chief Physician of the Pacemaker Service at the Dante Pazzanese Institute of Cardiology, Director of the Pacemaker and Arrhythmia Electrophysiology Service at the Heart Hospital, Chief Physician - Pacemaker and Arrhythmia Electrophysiology Service Dr. Pachón, and Chief Physician of the Arrhythmia Service at Professor Edmundo Vasconcelos Hospital. He has experience in Medicine, with an emphasis on Cardiac Arrhythmias, Cardiac Pacemakers, Defibrillators, and Electrophysiology, working primarily in the following areas: arrhythmia, electrophysiology, pacemakers, cardiac resynchronization devices, and defibrillators.

I completed a PhD program in Biotechnology at the Department of Physiology, Faculty of Medicine , University of Granada , in collaboration with the Department of Pharmaceutical and Organic Chemistry , where I analyzed the neuroprotective properties of >200 nitric oxide synthase (NOS) enzyme inhibitors in vitro . The compounds considered most promising were tested in an MPTP-induced mouse model of Parkinson's Disease (PD). I demonstrated for the first time the existence of an inducible mitochondrial NOS isoform. In 2008, I began my postdoctoral training sponsored by a prestigious Fulbright scholarship in the Department of Neurology directed by Dr. JT. Greenamyre , MD, PhD, Director of the Pittsburgh Institute for Neurodegenerative Diseases at the University of Pittsburgh and Chief of Movement Disorders, where I worked in areas related to neuroprotective strategies and molecular mechanisms of neurodegeneration.

I continued my career as a Research Associate at the University of Alabama at Birmingham, where I worked with Dr. Matthew Goldberg, PhD, Associate Professor in the Department of Neurology, studying how genetic mutations cause inherited forms of PD. In 2016, I was promoted to Instructor in the laboratory of Dr. M. Flint Beal , MD, Professor of Neurology at Harvard Medical School and Director of the Department of Neurology and Neuroscience at Weill Cornell Medicine (WCM), NY. During this time, I worked on the evaluation of novel therapeutic interventions in different transgenic mouse models of Alzheimer's disease (AD) and tauopathy, complemented by translational research studies. I then obtained an Assistant Professor position at the Brain and Mind Research Institute, WCM, where I worked on dissecting novel molecular mechanisms underlying pathological processes in neurodegeneration and developing effective treatments for PD and AD. I am currently a Distinguished Researcher at the Institute of Biology and Molecular Genetics of the University of Valladolid with a “María Zambrano” Excellence Program.

Dr. Andreia Morais is a postdoctoral research fellow at Massachusttes General Hospital/ Harvard University and has over 10 years of experience in neurovascular disease modeling in rodents, focusing on migraine and stroke. She is best known for her research on vagus nerve stimulation (VNS). Her study showed that VNS, using a non-invasive and side-effect free method, suppresses cortical spreadinh depression (CSD) comparable in magnitude to migraine prophylactic drugs through central pathways. CSD is an intense depolarization wave relevant in the pathophysiology of several neurological diseases, especially migraine and brain injury. Another highlight of her career is her participation in the Stroke Pre-Clinical Assessment Network (SPAN), a network that seeks to conduct late-stage preclinical stroke studies of putative neuroprotectants combined with reperfusion.

Dr. Mohamad Navab has received his PhD in Biochemistry from NY Columbia University during the period of 1970 to 1976. Currently, Dr. Navab is working as Professor of Medicine/Cardiology in UCLA University. He has successfully completed his Administrative responsibilities as Project Leader. He is serving as an editorial member of several reputed journals. He has authored 160 research articles/books. He is a member of American Heart Association. He has been honored as a recipient of NIH post Doctoral Awards

Associate Professor - University Medical Line, Medicine - Cardiovascular Medicine
Member, Bio-X
Member, Cardiovascular Institute
Member, Maternal & Child Health Research Institute (MCHRI)

1978 – 1985   Johann Wolfgang Goethe-University, Frankfurt/Main, Germany (Study of Medicine)

1981   Witwatersrand University, Baragwanath Hospital (Prof. du Plessis), Johannesburg, South Africa (Medical Clerkship)

1985  – 1986   Military Hospital, Internal Department (Oberstarzt Dr. Schmidt), Giessen, Germany (Surgeon Major)

1986  – 1987   German Heart Center Munich, Clinic for Heart und Circulatory Diseases (Prof. Rudolph), Munich, Germany (Resident)

1987  – 1998   Johannes Gutenberg University Clinic, 2nd Medical Clinic (Prof. Meyer), Mainz, Germany (Resident)

1988   Michael Reese Hospital, Division of Cardiology (Prof. Weber), Chicago, USA (Research Fellow)
1989   University of Virginia School of Medicine, Division of Cardiology (Prof. Kaul), Charlottesville, USA (Research Fellow)
1989   Harvard Medical School, Massachusetts General Hospital, Non-invasive Cardiac Laboratory (Prof. Weyman), Boston, USA (Research Fellow)
1988 – 1990   Emergency physician service (“Notfallärztlicher Dienst”), Ortenberg, Germany

1990 – 1998   Cardiology supervision of coronary sport’s group (secondary and tertiary cardiovascular prevention), Hofheim/Ts., Germany

1998 – 2004   Friedrich-Alexander University Clinic Erlangen-Nuremberg, 2nd Medical Clinic (Prof. Daniel), Erlangen, Germany (Consultant)

2004   Cooper Institute / Clinic (Dr. Cooper), Dallas, USA (Educational Program)

2005   European Prevention Center (CEO; grounding of company)

2019 EAPC Centre Accreditation in Cardiovascular Risk Management and Prevention des European Prevention Center (European Association of Preventive Cardiology (EAPC) der European Society of Cardiology (ESC))

2006   Leibniz-Institute for Arteriosclerosis Research at Westfälische Wilhelms-University Münster /Assmann-Siftung für Prävention (Prof. Assmann), Münster, Germany (Research Fellow)

2007 – today   European Prevention Center, Berlin, Germany (Medical CEO)

2007 – 2010   Private Cardiology Practice, Duisburg, Germany

2007 – 2010   European Prevention Center; Duisburg, Germany (Medical CEO)

2010 – today   Private Cardiology Practice, Düsseldorf, Germany

2010 – today   European Prevention Center, Düsseldorf, Germany (Medical CEO)

2010 – 2016   Dresden International University (DIU) (Honoray Professor of Master study course “Master of Science in Preventive Medicine (M.Sc.); 2015 and 2016 scientific leadership)

2015 – today   Hanako GmbH (Medical CEO)

Prof. Mario Oliveira graduated from Lisbon University and trained in Cardiology at St Marta’s Hospital, in Lisbon. He has interest in electrophysiology, catheter ablation, cardiac implantable devices, and arrhythmia mechanisms. His post-graduation mastership was in Sports Medicine and his major research activities involve ANS, arrhythmogenesis and cardiac implantable devices. PhD thesis - Molecular and Electrophysiological Basis of Autonomic Nervous System Influence in the Genesis and Maintenance of Paroxysmal Atrial Fibrillation. Author of >100 papers and member of several scientific societies. He is assistant professor of Physiology and PI at Cardiovascular Autonomic Lab at Lisbon Faculty of Medicine, Director of the Arrhythmology Unit of Santa Marta Hospital and head of department of cardiology at Hospital CUF, in Lisbon. He is past vice-president of the Portuguese Society of Cardiology and past-president of the Portuguese Association of Arrhythmology, Pacing and Electrophysiology.

Dr. Mayowa O. Owolabi is a distinguished academic and researcher specializing in public health, epidemiology, and neurology. With a robust academic background, Dr. Owolabi has held significant positions at prominent institutions, including the University College Hospital and the College of Medicine at the University of Ibadan in Nigeria. His tenure at these institutions has been marked by a commitment to advancing medical knowledge and improving health outcomes, particularly in the field of stroke and related disorders.

Dr. Owolabi's research contributions are widely recognized, with a focus on global health challenges such as the burden of stroke, musculoskeletal disorders, and visual impairment. His recent publications in esteemed journals like The Lancet and Eye highlight his dedication to addressing critical health issues through rigorous analysis and systematic reviews. Notably, his work on the global burden of diseases and risk factors has provided valuable insights that inform public health policies and interventions.

In addition to his academic roles, Dr. Owolabi has collaborated with various international organizations, including the World Stroke Organization and the Lancet, reflecting his influence in the global health community. His involvement in pilot randomized controlled trials and educational interventions demonstrates a proactive approach to translating research into practice, particularly in resource-limited settings.

Dr. Owolabi's extensive experience is complemented by sponsorship from leading research bodies, including the Medical Research Council and the Bill and Melinda Gates Foundation, underscoring his commitment to impactful research that addresses pressing health challenges. His work continues to inspire future generations of researchers and healthcare professionals dedicated to improving health outcomes worldwide.

Professor Aynur Özge is Professor of Neurology, Algology and Clinical Neurophysiology at Mersin University School of Medicine Department of Neurology in Turkey, an international lecturer, writer, and president of Global Migraine and Pain Summit together with MENA Organisation.

She is Co-Editor of three international books, two of them about childhood headaches, the other about peripheral interventions in headache medicine.

She has been an active member of IHS since 2004, and has actively served in the Child and Adolescent and Classification committees. She was elected to serve as a Co-opted Board member of the Society for the 2019–2021 term.

Professor Özge has served as the Organising Committee Chair of the 7th International Child-Adolescent Headache Congress held in Istanbul in 2008. She is the Organising Committee Chair of the 4th MENA and 2nd Turkish-African Migraine-Pain Congress, which was held in Antalya in 2020. She is the President of the Global Migraine Pain Summit, established in 2019 to raise social awareness about migraine and painful syndromes.

Professor Özge's H index score, is 26. She is the author of two public information books which are on sale to benefit various NGOs.

Dr Jeyaraj D Pandian is a Professor and Head of Neurology and the Principal/Dean from Christian Medical College (CMC), Ludhiana, Punjab, India. Dr Pandian is the current President  of World Stroke Organisation and Past President of Indian Stroke Association. He is a Fellow of the Royal Australasian College of Physicians, Fellow of Royal College of Physicians, Fellow of European Stroke Organization and Fellow of World Stroke Organisation (WSO).

Dr Pandian was the past Chair of World Stroke Campaign International Working Group of WSO. He has been a member of WSO Policy and Research Committees. Dr Pandian was the Co-chair of the World Stroke Congress 2016 held in Hyderabad, India. He is a member of the Strategic Advisory Group (STAG) for NCDs in WHO Geneva. Dr Pandian was conferred the WSO Global stroke services award in 2020 for his contributions to the field of stroke.

Dr Pandian has made significant contributions to stroke care services, epidemiology, and thrombolysis in low and middle-income countries. He is the National PI for the Indian Stroke Clinical Trial Network (INSTRuCT). 

Valeria Pergola is an Italian Non-invasive Consultant Cardiologist, graduated in Medicine (1997) and specialized in Cardiology (2001) with full marks and honors. 

Valeria Pergola as Senior Consultant in Cardiology and Adjunct Professor in Cardiology, Cardiac Imaging at Padua University Hospital. Her previous appointment was Lead of Cardiac Imaging (echocardiography and cardiac CT), at Croydon University Hospital, London,  and Consultant in Cardiac Imaging at Kings College Hospital, London and as Honorary Consultant at Royal Brompton Hospital, London from September 2016 to September 2019.

Other previous appointment (2012-2016) was Imaging Consultant at King Faisal Specialist Hospital and Research Center in Riyadh, Saudi Arabia, that has the biggest Cardiac Centre in the Middle East, doing clinical and diagnostic activities in particular in Cardiovascular Imaging by using echocardiography in cardiac and cardiac-surgery divisions. I started to work at KFSH&RC in 2012 under the direction of Prof. George Sutherland.

Previously,from 2007 to 2011 I worked at Azienda dei Colli Hospital in Naples, Italy (Ranked 2nd best Italian Hospital in 2012), where I have been Director of the Outpatient clinic of High Specialized Excellence Center of Cardiac complications in infectious diseases “D. Cotugno”.

Valeria Pergola started my experience in Echocardiography in 1997. Since 1999 she started to perform TTE. In 2000 I did one year of fellowship with Prof Gilbert Habib (Past President of EACVI) at “la Timone Hospital” in Marseille, to further study on TEE and infective endocarditis. 

Valeria Pergola, I have extensive experience in all different setting of clinical and research arena (ambulatory, ICU, operating room, adult congenital heart disease, and in clinical research). 

She got Certification of Competence in transthoracic (Italian and European) and transesophageal (Italian) echocardiography. 

She is active member of the European Association of Cardiovascular Imaging and of the Italian Society of Echocardiography.

She is member of the Society of Cardiovascular Computed Tomography.

She got Level 2 Certification of Competence in Cardiovascular Computed Tomography.

Valeria Pergola Fellow of the European society of Cardiology (FESC) and of the European Society of Cardiovascular Imaging (FEACVI).

Valeria Pergola, main fields of interest are Echocardiography, cardiac CT, TOE, stress echo, valve stress echo, valvular heart disease, cardiac complications of infectious diseases and adult congenital heart disease.

Emilio Perucca, MD, PhD, FRCP(Edin) is Clinical Professor in the Department of Medicine (Austin Health), The University of Melbourne. He is also Adjunct Professor in the Department of Neuroscience, Central Clinical School, Monash University, Melbourne.

He trained as a clinical pharmacologist and as a neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, in London, UK. He spent much of his career as Professor of Clinical Pharmacology and Therapeutics at the University of Pavia, Italy.

Prof. Perucca served as President of the International League against Epilepsy (ILAE) for the 2013-2017 term. He received several awards, including the ILAE-IBE Ambassador for Epilepsy Award in 1997, the European Epileptology Award in 2018, the Lifetime Achievement in Epilepsy Award from the Georgian League Against Epilepsy in 2019, and the Lifetime Accelerator Award from the U.S. Epilepsy Foundation in 2021.

Over the last 40 years, his research activities have focused on the clinical pharmacology of antiseizure medications, the treatment of seizure disorders, and outcome assessment in people with epilepsy. He has co-edited or contributed to several international textbooks and has authored over 500 Pubmed-listed publications, with an H-Index of 82 and a Citation Index over 30,000.

Prof. Dr.Ivo Petrov graduated from Sofia Medical University in 1992 and gained his specialization in Internal Medicine in 1999, and was board certified in Cardiology in 2003. Prof. Petrov also graduated Healthcare Management Program from Sofia University.

He has completed post-graduate medical course in Echo Stress testing in Wiesbaden, Germany and in 1999-2000 he was awarded a fellowship to specialize in Invasive Cardiology and Radiology in The Institute of Cardiology and Cardio-Vascular Surgery sponsored by the Favaloro Foundation in Buenos Aires, Argentina.

During the period 1992-2006, Dr. Petrov worked at «Saint Ekaterina» University Hospital and was nominated as an assistant professor of cardiology.

In November 2006, he was appointed to lead the Cardiology Department at Acibadem City Clinic Tokuda Hospital.

Since November 2012 he has been holding the position as Chief of Cardiology and Angiology Department at Acibadem City Clinic Cardiovascular Center.

I am an open cerebrovascular fellow at Barrow Neurological Institute. I completed neurosurgery residency at University of Rochester. During residency I developed interest in cerebral aneurysms both in preventing rupture and improving outcomes in delayed cerebral ischemia after rupture. I performed grant funded research on the role of vitamin D deficiency and senescent cells in the formation and rupture of aneurysms. I conducted two trials, including a multi-center randomized control trial on use of lumbar drains in the reduction of DCI. These experiences led to a textbook on management of lumbar drains and external ventricular drains. I also constructed, funded, and managed a state-of-the-art skull base laboratory. I also have a strong interest in innovation and device development. 

Prof Sutton became Professor of Clinical Cardiology at Imperial College, London in 2003 and Emeritus Professor in 2011. He is now Honorary Consultant Cardiologist at Imperial College Healthcare NHS Trust. From 1990 to 1995, he was President of British Heart Rhythm Society (then BPEG) after being Co-Founder in 1976. He has written and edited six books and published over 300 peer-reviewed papers, primarily on the topics of pacing and syncope.

Prof Sutton is a fellow of the American College of Cardiology, the European Society of Cardiology, the American Heart Association and the Heart Rhythm Society, among others. He has served as President of the Royal Society of Medicine Cardiology Section and actively participates in the British Cardiovascular Society and the British Medical Association.

Gustavo is a Professor of Medicine, Neurologist, Senior Scientist, and Healthcare Consultant at the University of Toronto. He holds a Master’s in Public Health (Epidemiology, Statistics) from Harvard and Buenos Aires Universities, a PhD in Neuroeconomics from the University of Zurich, and Leadership Certification from the Rotman School of Management and the Ontario Medical Association. With over 25 years as a clinician-scientist, educator, and team leader, he has become a recognized expert in his field.

Academic Work: Gustavo’s international acclaim is reflected through 30 grants as a principal investigator, 12 personal awards, 300+ peer-reviewed publications, keynote speaking invitations, contributions to 10 international best-practice guidelines, and service on advisory boards (e.g., World Stroke Organization, American Heart Association, Ontario Ministry of Health). His research integrates different disciplines: physiological methods, behavioral sciences, clinical research, psychology, and decision neuroscience to conduct research across observational studies, randomized trials, and meta-analyses.

Paul Schoenhagen, MD, is a Physician in the Department of Diagnostic Radiology and in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine. He is board-certified in internal medicine. His clinical interest is focused on cardiovascular imaging with computed tomography and magnetic resonance imaging. He is also involved in work related to the prevention of cardiovascular disease. Dr. Schoenhagen has a special interest in imaging of coronary atherosclerosis and imaging of the aorta and aortic root.

A native of Koblenz, Germany, Dr. Schoenhagen graduated with a degree in mineralogy from the Ruhr-Universitaet, Bochum, Germany. He received his medical degree from the Karls-Universitaet, Tuebingen, and doctoral degree from the Philips-Universitaet, Marburg, also in Germany. He received his initial clinical training in internal medicine and radiology in Stuttgart, Germany. This was followed by a residency in internal medicine at Cleveland Clinic, and subsequent fellowships in cardiology and in cardiovascular tomography, also at Cleveland Clinic. Dr. Schoenhagen was appointed to Cleveland Clinic in 2003.

Dr. Schoenhagen has been honored for his clinical research, which has focused on the implications of plaque vulnerability, intravascular ultrasound research and the application of computed tomography and magnetic resonance imaging for atherosclerosis research.

He has published numerous original and review articles in leading peer-reviewed journals such as the Journal of the American Medical Association, Circulation, the Journal of the American College of Cardiology, the European Heart Journal, and the Journal of Heart and Lung Transplantation. Dr. Schoenhagen is first author of a textbook of Coronary Intravascular Ultrasound Imaging, and a textbook of Cardiovascular Computed Tomography. He has contributed to several chapters in other medical textbooks related to his specialty interests. He has been invited to present his clinical experience and research at medical symposia and conferences in Japan, Europe, and nationally.

Dr. Schoenhagen is a Fellow of the Council on Atherosclerosis, Thrombosis and Vascular Biology of the American Heart Association. He is a member of the American College of Physicians, the European Society of Cardiology and the Radiologic Society of North America. He is an affiliate member of the American College of Cardiology.

Dr. Anwen Shao is an Attending Physician at The Second Affiliated Hospital of Zhejiang University School of Medicine. He received his Doctor of Philosophy from Zhejiang University. His research interests are Neurosurgery, Brain Injury, Neurological Disease, Neurovascular Disease, Traumatic Brain Injury, Stroke, Subarachnoid Hemorrhage, Intracerebral Hemorrhage, and Neurology.

Primary Position:  Associate Professor, YLL School of Medicine, National University of Singapore

Dr. Vijay K Sharma is Associate Professor at National University of Singapore, Singapore and Senior Consultant Neurologist at National University Hospital, Singapore. He is the current recipient of the prestigious Senior Clinician Scientist Award from National Medical Research Council, Ministry of Health, Singapore.

He has co-authored 375 peer-reviewed papers in reputed scientific journals including New England Journal of Medicine, The Lancet, Lancet Neurology, Annals of Neurology, Circulation, Neurology and Stroke etc. He has edited 2 books and co-authored 43 book chapters.

He is member of Stroke Guidelines Committee at World Stroke Organization and Co-Chair of WSO oversight committee for International Journal of Stroke. He serves as Associate Editor for Frontiers in Neurology, BMC Neurology, Exploration of Neuroprotective Therapy and British Journal of Medicine and Medical Research. He serves on the editorial boards of many scientific journals including Stroke, Journal of Neuroimaging, Journal of Stroke etc. His research interests include acute stroke thrombolysis, intracranial stenosis and advanced applications of cerebrovascular ultrasonography in cerebrovascular ischemia.

Dr. Huaxin Sheng is an associate professor in the Department of Anesthesiology at Duke University Medical Center. He received his medical degree and advanced training in neurosurgery in China. In 1996, he joined Dr. David S Warner’s laboratory at Duke where he has developed a number of mouse disease models, including ischemic stroke, cardiac arrest, and subarachnoid hemorrhage models. His current research is focused on preclinical development of novel pharmaceutical treatments for stroke and related vascular diseases.

Head of Neuroimmunology Group, Neurology Branch, Chinese Medical Association
Chairman of China Neuroimmunology Alliance
Chairman of Tianjin Stroke Society
Member of the Core Decision Committee and Chairman of the Academic Committee of Pan-Asian Treatment and Research for Multiple Sclerosis (PACTRIMS)
Member of the American College of Cardiology
Chairman of Tianjin Neurology Branch
Standing Member of the Committee of Neurology Branch, Chinese Medical Association
Member of the American Neurological Association
Member of the American Immunology Association

Dr. Sia Ching Hui obtained his medical education at the Yong Loo Lin School of Medicine, National University of Singapore, graduating in 2012. In 2015, he was granted membership in the Royal College of Physicians of the United Kingdom, followed by the completion of his Master of Medicine in Internal Medicine in 2016. Dr. Sia successfully finished his Internal Medicine Residency in 2017 at NUHS, where he also served as the Academic Chief Resident. Subsequently, he completed his Cardiology Senior Residency with NUHS in 2020. During his residency training, he participated in the Singapore Chief Residency Programme (Cohort 6). In 2021, Dr. Sia attained his Master of Clinical Investigation degree from NUS, supported by a Ministry of Health Healthcare Research Scholarship, and followed it with an Executive Master of Business Administration from the Quantic School of Business and Technology in 2022.

Dr. Sia's clinical and research interests revolve around the utilization of multi-modality cardiac imaging to explore disease mechanisms, facilitate diagnosis, prognosis, and guide patient management. He has a strong interest in Cardio-Neurology and cardiomyopathies.

Additionally, Dr. Sia concurrently holds an academic appointment as a Junior Academic Fellow in the Department of Medicine at the Yong Loo Lin School of Medicine through the selective Junior Academic Fellowship Scheme. To date, he has secured several research grants, including the National Medical Research Council's Clinician Scientist Individual Research Grant New Investigator Grant in 2021 and the Transition Award in 2023. Dr. Sia has a publication record of over 200 papers in peer-reviewed journals. He serves on the Cardiovascular Disease National Collaborative Enteprise (CADENCE) executive committee. He also serves as a Cardiology specialty editor for the Singapore Medical Journal and sits on the editorial boards of multiple journals. He frequently presents at international conferences and actively contributes as a reviewer for various journals.

Moreover, Dr. Sia is a dedicated educator. In 2018, he received a Certificate in Medical and Health Professions Education from the Centre for Medical Education at NUS, and in 2019, he completed the NUHS Medical Education Distinction Track Residency. Dr. Sia regularly conducts tutorials for medical students, serves as an examiner, and fulfills mentoring roles within different mentorship programs associated with the Yong Loo Lin School of Medicine. He was previously awarded the NUS Medicine Dean’s Award for Teaching Excellence. He possesses substantial experience in organizing courses and overseeing students' clinical and research attachments.

International Expert in Neuro-Cardiology, Chronobiology and Nutraceuticals, antioxidants (Regenerative Medicine).

1.Stanford Univ. List 2020, One of Top Four CVD Scientist of India and out of 1500 top CVD scientists in the world.

2.Received 12 International awards including Dr Zumkley Memorial award;

3.Fellow of the International Academy of Cardiovascular Sciences, Winnepeg, Canada, 2014

4.President, Tsim Tsoum Institute, Krakow, Poland. Member, Russian Academy of Medical Sciences, Former President & Founder, Indian Society of Hypertension, International College of Cardiology and International College of Nutrition.

5.President, Indian Society of Chronomedicine 2017-2018.

6.Fellow, Bulgarian Academy of Sciences, 2019, Russian Adedemy of Medical Sciences, Lifetime Achievement award 2020, Indian Society of Hypertension.

Member of the National Cardiovascular Disease Expert Committee, leader of the expert working group of the Cardiomyopathy Specialty Alliance of the National Cardiovascular Disease Center, deputy leader of the Precision Cardiovascular Disease Group of the Cardiovascular Disease Branch of the Chinese Medical Association, standing committee member and secretary-general of the China Medical Health International Exchange to Promote Cardiovascular Disease Precision Medicine Branch, and standing committee member of the Hypertension Professional Committee of the Chinese Medical Doctor Association.

Professor of Internal Medicine - Cardiovascular Medicine

Edith King Pearson Chair in Cardiovascular Research

Dr. Zhonghua Sun is a Professor of Medical Radiation Science at Curtin University, Perth, Australia. He obtained his PhD in 2002 from the University of Ulster, where he worked as a lecturer in radiography for two and a half years before joining Curtin University as a lecturer of medical radiation science in 2005. His research interests include 3D medical image visualization and processing, in particular cardiovascular CT imaging and 3D printing, virtual reality, and AI in cardiovascular diseases. He has published five books, 14 book chapters, and more than 350 refereed papers in medical and medical imaging journals. He is a Fellow of the Society of Cardiovascular Computed Tomography. He also serves as an Associate Editor/Academic Editor for six journals and is an Editorial Board Member for more than 20 international imaging/medical journals.

Dr. Benjamin Tan is a Vascular Neurologist at the National University Hospital in Singapore, specializing in the care of young adults with ischemic stroke. In addition to his clinical practice, he serves as an Adjunct Assistant Professor at the Yong Loo Lin School of Medicine, National University of Singapore (NUS), and holds a joint appointment as Principal Investigator with the Institute of Molecular and Cell Biology (IMCB), A*STAR. He also contributes to the local academic community as Specialty Editor (Neurology) for the Singapore Medical Journal. Dr. Tan is also a committee member of the New Scientific Initiatives Taskforce of the Council on Stroke, European Society of Cardiology (ESC). 

Dr. Tan was a Post-Doctoral Research Fellow from 2024-2025, training in computational biology and stroke genetics at the Centre for Genomic Medicine, Massachusetts General Hospital, USA and Broad Institute of MIT and Harvard, USA under the supervision of Professor Jonathan Rosand and Professor Christopher D Anderson. His current research focuses on ischemic stroke in young adults, including the characterization of genetics and biomarkers that help in understanding the disease pathogenesis, predicting severity, recovery and long term outcomes. He also has a special interest in distilling and investigating the heart-brain interactions that surround ischemic stroke. He has published more than 250 manuscripts in international peer-reviewed journals including the Lancet Public Health, JAMA Neurology, Stroke, Journal of Stroke and International Journal of Stroke, and has been recognized on Stanford-Elsevier Top 2% Scientists List in 2022, 2023 and 2024. 

Francesco Tona, MD, PhD, FAHA, FESC is professor of cardiology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy. Professor Tona’s key achievements include research on the development of new noninvasive diagnostic tools for evaluating cardiac allograft function in heart transplantation, with particular interests in allograft vasculopathy and coronary microvascular injury; new diagnostic tools (echocardiography and cardiac magnetic resonance) to identify microvascular dysfunction in cardiomyopathies and heart failure; the aetiology of cardiac allograft vasculopathy; the aetiopathogenesis of cardiomyopathies and myocarditis; determination of new prognostic indexes in heart failure (biomarkers and imaging); the development of new diagnostic and prognostic tools in pulmonary hypertension and embolism; and cardiac involvement in systemic inflammatory diseases and endocrine diseases.

Moris Topaz, M.D., Ph.D., is an expert in the field of Plastic Surgery and is highly involved in researching matters relating to advanced medical technologies. He holds a B.Sc. in Chemistry, a Medical Degree from Ben Gurion University, a Masters Degree Cum Laude in Plastic Surgery from the University of Tel-Aviv and a Ph.D. from Ben Gurion University. He specialized in Plastic Surgery at the Chaim Sheba Medical Center, and practiced Plastic & Reconstructive Surgery in the United States.

Dr. Topaz specializes in aesthetic plastic surgery, including cosmetic surgery of the eyelids, nose, face and breasts: and reconstructive surgery of the breasts, eyelids, and after resection of skin tumors. He currently researches and develops original technologies and a variety of innovative devices to enhance and improve wound-healing.

Ulrich F. W. Franke, Department of Cardiovascular Surgery, Robert Bosch Hospital, Stuttgart, Germany

Matthias Schwab, Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany

Sotirios Tsimikas, Department of Medicine, University of California San Diego

Arnold von Eckardstein, Institute of Clinical Chemistry, University of Zurich and University Hospital of Zurich, Zurich, Switzerland

Prof Georgios Tsivgoulis M.D., Ph.D., MSc, FESO, FEAN is Professor of Neurology and Vice-Chairman in the Department of Neurology at the National & Kapodistrian University of Athens, School of Medicine in Greece. He is the Divisional Director of Cerebrovascular Diseases, Director of the Neurosonology Laboratory and Director of Residential Training and the Cerebrovascular Fellowship Program. He is also a Visiting Professor of Neurology and Director of Stroke Research, in the Department of Neurology, University of Tennessee Health Science Center in Memphis, TN. His research interests focus on acute reperfusion therapies in acute ischaemic stroke, applications of neurosonology in cerebrovascular diseases, secondary stroke prevention, and clinical trial methodology. Prof Tsivgoulis serves on the board of Directors for the European Stroke Organization (ESO) and is the Chair of the International Liaison Committee (ESO). Prof Tsivgoulis has published more than 300 original papers and 11 chapters in international medical journals in the field of cerebrovascular diseases.

Mehmet Turgut, MD, PhD, graduated from the Ege University School of Medicine, ?zmir, Turkey and later specialized in neurosurgery at Hacettepe University Hospital, Ankara, Turkey. In 2004, he received his PhD from the Department of Embryology and Histology, Ege University Health Sciences Institute, ?zmir, Turkey. He is currently Assistant Professor in the Department of Neurosurgery, Adnan Menderes University School of Medicine, Ayd?n, Turkey. His fields of expertise and research interests are broad and include developmental neuroscience, pediatric neurosurgery, infectious diseases of the central nervous system, and peripheral nerve surgery. Dr. Turgut is an editorial board member for 17 international journals, including Central European Neurosurgery, Journal of Spine, Journal of Pediatric Neurology, Journal of Spine & Neurosurgery, and Journal of Neurosciences in Rural Practice, and a reviewer for a wide range of international journals and research programs. He is the lead or co-author of numerous publications in international journals as well as many book chapters and other publications.

Professor Ahmad Umar is at the forefront of research in nanoscience and nanotechnology, areas that explore materials at the nanoscale, between 1-100 nanometers. In simpler terms, he's working with incredibly tiny materials to address some of the most pressing challenges facing our environment and energy sectors. Whether it's developing sensors to detect pollutants, designing catalysts to facilitate cleaner chemical reactions, membranes for separation technologies, or creating advanced materials for renewable energy technologies like solar cells, supercapacitors, and batteries, Professor Umar's work covers a broad spectrum of applications aimed at making our world cleaner and more sustainable.

President of the World Institute of Pain President, Paolo Procacci Foundation General Manager, ASL Teramo, Public Company of the National Health Care Service President of the European Pain Federation (EFIC) President of Clinicians Council, UNIVAQ Full Professor, Anesthesia and Pain Medicine, UNIVAQ Assoc. Professor of Anesthesia and Pain Medicine, UNIVAQ Chairman, Dept. of Anesthesia, UNIVAQ Invited Professor, Dept. of Anesthesia, University of Barcelona, Spain Invited Professor, Dept. of Anesthesia, University of Massachusetts, Worchester, MA, USA; and University of Tel-Aviv, Israel Assist. Professor of Anesthesia and Pain Medicine, UNIVAQ, L’Aquila, Italy Researcher, University of Roma, Italy Researcher, University of Hamburg, Germany Researcher CNR-NIH, Albert Einstein College of Medicine, Yeshiva University, New York, NY, USA

Madeeha Subhan Waleed is an academic researcher from Ayub Medical College. The author has contributed to research in topics: Medicine & Disease. 

Wang Yibo is a researcher and doctoral supervisor at the Fuwai Hospital of the Chinese Academy of Medical Sciences, and a PI of the State Key Laboratory of Cardiovascular Diseases at the National Center for Cardiovascular Diseases. He has won the National Excellent Young Scientist Fund, Peking Union Medical College Rising Star, Xicheng District 100 Talents, and Beijing Science and Technology Rising Star. He is also a member of the Standing Committee of the Youth Federation of Xicheng District, Beijing, the deputy editor-in-chief of the Chinese Journal of Molecular Cardiology, the editorial board member of the Chinese version of Nature Reviews Cardiology, and the editorial board member of the Chinese Journal of Misdiagnosis Medicine.

Professor, Biomedical Engineerin, 2021-Present

Professor and Chairperson, Department of Physiology Augusta University, 1999-2020

Professor (Assistant to Full), University of Michigan, 1979-99

Research Associate, Universitaire Instelling Antwerpen, 1978-79

Postdoctoral Fellow, University of Michigan, 1976-78

University of Iowa, Ph.D. (Anatomy), 1973-76

Southern Illinois University, M.S. (Physiology), 1971-73

Southern Illinois University, B.A. (Physiology), 1967-71

George K.C. Wong is an academic researcher from The Chinese University of Hong Kong. The author has contributed to research in topics: Subarachnoid hemorrhage & Medicine. The author has an hindex of 35, co-authored 236 publications. 

Jialing Wu received the M.D. degree from Huaxi Medical University, Chengdu, China, in 2007, and the Ph.D. degree in neurology from Tianjin Medical University, Tianjin, China, in 2011.,He is a Chief Physician, a Ph.D. Supervisor, and the Director of the Department of Neurology and Rehabilitation, Tianjin Neurosurgical Institute, Tianjin. He went on to his postdoctoral study of ischemic stroke with the Department of Neurology, Emory University, Atlanta, GA, USA. He is currently focusing on basic and clinical research for stroke and Parkinsonism.

Xu Dong is the director, chief physician, professor, and doctoral supervisor of the Heart and Vascular Disease Center of Beijing Tiantan Hospital affiliated to Capital Medical University.
He holds a doctorate in medicine from the University of Queensland School of Medicine in Australia. He has been engaged in heart and vascular surgery for more than 30 years and is good at coronary heart disease bypass surgery, heart valve replacement surgery, aortic surgery, and congenital heart disease correction.

Chief physician, professor, doctoral supervisor, executive member of the World Federation of Neurology, chairman of the Neuro-Ultrasound Committee of the Chinese Medical Association, deputy leader of the Neuro-Imaging Collaboration Group of the Neurology Branch of the Chinese Medical Association, deputy director of the Neuroscience Committee of the Chinese Association of Research Hospitals, deputy director of the Translational Medicine Branch of the Chinese Stroke Society, deputy editor-in-chief of Annals of Translational Medicine (SCIE), deputy editor-in-chief of BMC Neurology (SCIE), executive editor of the Chinese Journal of Cerebrovascular Diseases, editor of the Chinese Journal of Cerebrovascular Diseases (electronic version), editor of the Journal of Stroke and Neurological Diseases, and editor of the Chinese Journal of Practical Internal Medicine. He has been engaged in clinical, teaching and scientific research work in neurology for a long time. His clinical expertise is cerebrovascular disease, intracranial atherosclerosis, dizziness, headache and other common and difficult central nervous system diseases. He is the editor-in-chief of "Case Analysis in Neurology - Introduction and Improvement", "Illustrated Guide to Cerebrovascular Diseases" (People's Medical Publishing House), and the main translator of "Discussion of Difficult Cases in Neurology" (Peking Union Medical College Press). He presided over the National Key R&D Program, the National Natural Science Foundation and the NIH Fund Project. He has published more than 20 papers as the first and corresponding author in famous international journals such as Annals of Neurology, Neurology, and Stroke.

Zhang Jian, doctor of medicine, chief physician, professor, doctoral supervisor. He is currently the director of the Heart Failure Center and the HFCU of the Fuwai Hospital of the Chinese Academy of Medical Sciences, deputy director of the National Clinical Research Center for Cardiovascular Diseases, chairman of the Heart Failure Committee of the Chinese Medical Association, deputy leader of the Heart Failure Group of the Cardiovascular Disease Branch of the Chinese Medical Association, director of the Cardiovascular Committee of the Chinese Society of Pathophysiology and member of the Chinese Branch of the International Society for Heart Research (ISHR), deputy director of the Emergency Medicine Branch of the Beijing Medical Association, and deputy director of the Cardiovascular Critical Care Medicine Committee of the Cross-Straits Medical and Health Exchange Association.

Zhang Wei, MD, is a postdoctoral fellow at MD Anderson Cancer Center in the United States. He is a neurosurgeon, chief physician, associate professor, doctoral supervisor, and deputy director of the Fifth Department of Neurosurgery Tumors at Beijing Tiantan Hospital affiliated to Capital Medical University. He is specialized in: minimally invasive surgical treatment of common cranial brain tumors, especially surgical treatment and postoperative comprehensive treatment of gliomas in the functional areas of the brain, and has been engaged in the research of molecular mechanisms and innovative diagnosis and treatment technologies of gliomas for a long time.

He is also a member of the Youth Council of the China Anti-Cancer Association, deputy director of the Youth Committee of the Brain Glioma Professional Committee of the Chinese Medical Doctor Association, national member of the Brain Glioma Professional Committee of the China Anti-Cancer Association, standing member of the Neuro-Oncology Branch of the Chinese Society of Neuroscience, and member of the American Society of Neuro-Oncology.

Deputy Director of the Valve and Atrial Fibrillation Surgery Center, Doctoral Supervisor, Professor of Capital Medical University, presided over more than ten scientific research projects such as international cooperation projects, National Natural Science Foundation of China, Beijing Municipal Science and Technology Commission, etc.

National Committee Member of the Chinese Medical Association Cardiac Surgery Branch and Vice Chairman of the Structural Heart Disease Committee and Vice Chairman of the Atrial Fibrillation Committee. Standing Committee Member and Secretary General of the Asian Heart Valve Society China Branch, Vice Chairman and Secretary General of the Valvular Disease Intervention Committee. Secretary General of the Heart Valve Disease Committee of the Chinese Research Hospital Association, Standing Committee Member of the Atrial Fibrillation Committee. Member of the Department of Cardiac Surgery of Capital Medical University. Won the Beijing Municipal Science and Technology Commission Science and Technology Rising Star, Beijing Municipal Party Committee Organization Department Outstanding Talent, Beijing Municipal Science and Technology Progress Award, Ministry of Education Scientific Research Outstanding Achievement Award, Beijing Municipal Health Bureau Discipline Backbone, Beijing Outstanding Young Intellectual, Chinese Cardiac Surgeon of the Chinese Medical Association, Life Times Honor Doctor Youth Innovation Award, National Doctor Young Prodigy and other awards and titles.

Viviane Flumignan Zétola is an academic researcher from Federal University of Paraná. The author has contributed to research in topics: Stroke & Medicine. 

Çiçek is an internationally recognized leader in congenital cardiac surgery. He is a Fellow of American College of Surgeons, American College of Cardiology, and American College of Chest Physicians. He is a member of the American Association for Thoracic Surgery (AATS), Society of Thoracic Surgeons, European Association for Cardio-Thoracic Surgery, Association for European Pediatric Cardiology, Asian Society for Cardiovascular and Thoracic Surgery (ASCVTS), European Congenital Heart Surgeons Association (ECHSA), Congenital Heart Surgeons Society, and World Society for Pediatric and Congenital Heart Surgery (WSPCHS).

He served on the Councils of ASCVTS and WSPCHS, as well as the Steering Committee of the World Congress of Pediatric Cardiology and Cardiac Surgery, the Board of Directors of ECHSA, and the Membership and Education committees of AATS. Çiçek served as the Chairman of Seventh World Congress of Pediatric Cardiology and Cardiac Surgery, which is considered to be the one of the highest honors in the pediatric and congenital cardiac profession.